Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
170,107,714
-
Total 13F shares
-
139,179,591
-
Share change
-
+19,356,015
-
Total reported value
-
$2,250,311,406
-
Put/Call ratio
-
108%
-
Price per share
-
$16.17
-
Number of holders
-
174
-
Value change
-
+$303,421,206
-
Number of buys
-
89
-
Number of sells
-
83
Institutional Holders of ACADIA PHARMACEUTICALS INC - Common Stock, $0.0001 par value (ACAD) as of Q4 2018
As of 31 Dec 2018,
ACADIA PHARMACEUTICALS INC - Common Stock, $0.0001 par value (ACAD) was held by
174 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
139,179,591 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, FMR LLC, Vanguard Group Inc, BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, FIRST TRUST ADVISORS LP, OppenheimerFunds, Inc., JANUS HENDERSON GROUP PLC, and CITADEL ADVISORS LLC.
This page lists
174
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.